Searchable abstracts of presentations at key conferences in endocrinology

ea0073ep81 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Covid-19 and dexamethasone treatment as a cause of Hyperosmolar Hyperglycaemic State in a patient with unknown diabetes mellitus before. A case report

Kermaj Marjeta , Mihaj Ina , Xhemollari Ira , Xhindi Marsela , Ylli Agron

IntroductionCOVID-19 can precipitate hyperglycaemic emergencies like Hyperosmolar Hyperglycaemic State (HHS) in patients with or without DM. It is currently hypothesized that COVID-19 may have a diabetogenic effect in addition to the stress-related response of glucose metabolism in severe illness. Dexamethasone reduces mortality in people with COVID-19 who require ventilation or oxygen therapy but can impair glucose metabolism. We present a case with HHS...